Wybrane zioła w prewencji i wspomaganiu leczenia wirusowych infekcji dróg oddechowych

• Authors: Paweł Siudem

Title variants

EN

Selected herbs in the prevention and treatment of viral respiratory infections

Abstracts

EN

Every year, during the cold and flu season, an increase in the incidence of viral respiratory infections and other viral diseases is observed. Vaccination is the primary method of preventing viral diseases. However, it is not always possible to be vaccinated, or the immunity expires after some time. Numerous plant materials can support both prevention and treatment. This article provides an overview of a few selected plant materials, mainly focusing on their impact on influenza and COVID-19 infection.

PL

Każdego roku w sezonie przeziębień i grypy obserwuje się wzrost zachorowań na wirusowe infekcje dróg oddechowych oraz inne choroby wirusowe. Podstawowym sposobem zapobiegania chorobom wirusowym są szczepienia. Nie zawsze jednak możliwe jest przyjęcie szczepienia bądź odporność po pewnym czasie wygasa. Wsparciem zarówno w zapobieganiu, jak i leczeniu mogą być liczne surowce roślinne. W tym artykule przedstawiono przegląd kilku wybranych surowców roślinnych, głównie skupiając się na ich wpływie na grypę i infekcję koronawirusem COVID-19.

Keywords

PL

grypa; COVID-19; substancje roślinne

EN

influenza; COVID-19; natural products

• Publisher: Wydawnictwo Naukowe Medyk sp. z o.o.
• Journal: Lek w Polsce
• Year: 2022
• Volume: 375
• Issue: 07-08
• Pages: 13-20

Dates

published

2022

Contributors

author

Paweł Siudem

• Katedra Farmacji Fizycznej i Bioanalizy, Zakład Chemii Fizycznej, Wydział Farmaceutyczny z Oddziałem Medycyny Laboratoryjnej, Warszawski Uniwersytet Medyczny

• https://orcid.org/0000000286743774

References

• Ferreira, S.S.; Silva, A.M.; Nunes, F.M.J.F.R.I. Sambucus nigra L. fruits and flowers: Chemical composition and related bioactivities. 2022, 38, 1237-1265.
• Torabian, G.; Valtchev, P.; Adil, Q.; Dehghani, F.J.J.o.f.f. Anti-influenza activity of elderberry (Sambucus nigra). 2019, 54, 353-360.
• Bhakuni, R.; Jain, D.; Sharma, R.; Kumar, S.J.C.s. Secondary metabolites of Artemisia annua and their biological activity. 2001, 35-48.
• Zhou, Y.; Gilmore, K.; Ramirez, S.; Settels, E.; Gammeltoft, K.A.; Pham, L.V.; Fahnøe, U.; Feng, S.; Offersgaard, A.; Trimpert, J.J.S.R. In vitro efficacy of artemisinin-based treatments against SARS-CoV-2. 2021, 11, 1-14.
• Jalmakhanbetova, R.I.; Suleimen, Y.M.; Oyama, M.; Elkaeed, E.B.; Eissa, I.; Suleimen, R.N.; Metwaly, A.M.; Ishmuratova, M.Y.J.J.o.C. Isolation and in silico anti-COVID-19 main protease (Mpro) activities of flavonoids and a sesquiterpene lactone from Artemisia sublessingiana. 2021, 2021.
• Basurra, R.S.; Wang, S.M.; Alhoot, M.A.J.J.P.A.M. Nigella safiva (black seed) as a natural remedy against viruses. 2021, 15, 29 41.
• Khazdair, M.R.; Ghafari, S.; Sadeghi, M.J.P.b. Possible therapeutic effects of Nigella sativa and its thymoquinone on COVID-19. 2021,59, 694-701.
• Josling, P.J.A.i.t. Preventing the common cold with a garlic supplement: a double-blind, placebo-controlled survey. 2001, 18, 189-193.
• Cinatl, J.; Morgenstern, B.; Bauer, G.; Chandra, P.; Rabenau, H.; Doerr, H.J.T.L. Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus. 2003, 361, 2045-2046.
• Vicidomini, C.; Roviello, V.; Roviello, G.N.J.S. In silico investigation on the interaction of chiral phytochemicals from opuntia ficus-indica with SARS-CoV-2 Mpro. 2021, 13, 1041.
• Timmer, A.; Guenther, J.; Motschall, E.; Ruecker, G.; Antes, G.; Kern, W.V.J.C.D.o.S.R. Pelargonium sidoides extract for treating acute respiratory tract infections. 2013.
• Demirci, F.; Karadağ, A.E.; Biltekin, S.N.; Demirci, B.J.R.o.N.P. In vitro ACE2 and 5-LOX inhibition of Rosmarinus officinalis L. Essential oil and its major component 1, 8-cineole. 2022.
• Sardari, S.; Mobaiend, A.; Ghassemifard, L.; Kamali, K.; Khavasi, N.J.J.o.A.i.M.; Research, B. Therapeutic effect of thyme (Thymus vulgaris) essential oil on patients with COVID-19: A randomized clinical trial. 2021, 29, 83-91.
• Watanabe, I.; Kuriyama, S.; Kakizaki, M.; Sone, T.; Ohmori-Matsuda, K.; Nakaya, N.; Hozawa, A.; Tsuji, I.J.T.A.j.o.c.n. Green tea and death from pneumonia in Japan: the Ohsaki cohort study. 2009, 90, 672-679.
• Ide, K.; Yamada, H.; Matsushita, K.; Ito, M.; Nojiri, K.; Toyoizumi, K.; Matsumoto, K.; Sameshima, Y.J.P.O. Effects of green tea gargling on the prevention of influenza infection in high school students: A randomized controlled study. 2014, 9, e96373.
• Matsumoto, K.; Yamada, H.; Takuma, N.; Niino, H.; Sagesaka, Y.M.J.B.c.; medicine, a. Effects of green tea catechins and theanine on preventing influenza infection among healthcare workers: a randomized controlled trial. 2011, 11, 1-7.
• Lee, C.-S.; Lee, J.-H.; Oh, M.; Choi, K.-M.; Jeong, M.R.; Park, J.-D.; Kwon, D.Y.; Ha, K.-C.; Park, E.-O.; Lee, N.J.J.o.K.M.S. Preventive effect of Korean red ginseng for acute respiratory illness: a randomized and double-blind clinical trial. 2012, 27, 1472-1478.
• Scaglione, F.; Cattaneo, G.; Alessandria, M.; Cogo, R.J.D.u.e.; research, c. Efficacy and safety of the standardised Ginseng extract G115 for potentiating vaccination against the influenza syndrome and protection against the common cold [corrected]. 1996, 22, 65-72.
• Predy, G.N.; Goel, V.; Lovlin, R.; Donner, A.; Stitt, L.; Basu, T.K.J.C. Efficacy of an extract of North American ginseng containing poly- furanosyl-pyranosyl-saccharides for preventing upper respiratory tract infections: a randomized controlled trial. 2005, 173, 1043-1048.
• Mcelhaney, J.E.; Gravenstein, S.; Cole, S.K.; Davidson, E.; O’neill, D.; Petitjean, S.; Rumble, B.; Shan, J.J.J.J.o.t.A.G.S. A placebo-controlled trial of a proprietary extract of North American ginseng (CVT-E002) to prevent acute respiratory illness in institutionalized older adults. 2004, 52, 13-19.

Identifiers

DOI

10.57591/LEK.202208.02

Biblioteka Nauki

2138924